[Cor bovinum: decreased incidence over the last 20 years--a therapeutic success?]
Related Experiment Video
Updated: Oct 2, 2026

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
1Pathologisches Institut, Kantonsspital Luzern.
Insights
Cor bovinum (CB), a significantly enlarged heart, is a common autopsy finding. Its frequency is decreasing, possibly due to advances in cardiovascular treatment, though it remains linked to sudden cardiac death.
Area of Science:
- Cardiovascular Pathology
- Forensic Medicine
- Internal Medicine
Context:
- Cor bovinum (CB), a heart weighing over 500g, is frequently observed in autopsies of patients with unclear causes of death.
- Cardiomyocyte hypertrophy and interstitial fibrosis in CB can lead to electromechanical instability and sudden cardiac death.
Purpose:
- To compare the frequency of Cor bovinum (CB) and associated pathologies in two distinct 4-year periods (1978-1981 and 1997-2000).
- To analyze trends in CB prevalence, patient demographics, and risk factors over two decades.
Summary:
- A retrospective autopsy study of 1181 patients revealed a decrease in CB prevalence from 25.3% (1978-1981) to 20.6% (1997-2000).
- The mean age at death increased significantly, with hypertension, COPD, and male sex identified as primary risk factors for CB. In 84% of CB cases, death was directly related to the condition.
- Despite a decreasing trend, CB remains a frequent finding, often associated with clinically unclear causes of death.
Impact:
- The observed decrease in CB frequency and increase in age at death suggest improved cardiovascular care and therapeutic interventions.
- Findings highlight the importance of managing hypertension and COPD to mitigate risks associated with Cor bovinum.
- This study provides valuable insights into the evolving landscape of cardiovascular pathology and its clinical implications.
Background:
The Cor bovinum (CB), a heart of > 500 g, is often found in patients with clinically unclear cause of death. Cardiomyocyte hypertrophy and increase of the interstitial connective tissue can lead to electromechanical instability and consecutive sudden heart death.
Methods:
This retrospective, autopsy-protocol-based study compared the frequency of altogether 415 CB and associated pathologies in two 4-year periods (1978-1981 and 1997-2000), including only patients of the Clinic of Internal Medicine (n = 1181 autopsies).
Results:
A CB was found in 25.3% of the patients of the first period (1978-1981) in contrast of 20.6% in the second period (1997-2000); hence, the frequency of CB is decreasing (0.05 > p > 0.02). The mean age at death was 67.7 years in 1978-1981 and 74.3 years in 1997-2000; this revealed an increasing trend (p < 0.001). The male-female proportion was 4:1. In 93% of all patients with CB, we found coronary atherosclerosis as a sign of high blood pressure and in 79% a COPD. In 84% of all cases with CB the cause of death was directly related to the CB, in 37% of these patients the cause of death was clinically unclear.
Conclusions:
The CB is a decreasing but still frequent autopsy-finding. We consider high blood pressure, COPD and male sex as the main risk factors. The decrease in frequency of CB and the increase in age at death might be interpreted as the effect of a successful application of new therapeutic standards in the last two decades (ACE-inhibitors, beta blockers, statins, PTCA, surgical heart interventions).
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Therapeutic Drug Monitoring: Affecting Factors
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Therapeutic Index
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

